This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.
Adults ≥ 18 years old
Diagnosed with pancreatic adenocarcinoma undergoing active treatment or planning to start active treatment within the next 30 days
English speaking
Access to a smartphone (Android or iOS)
Prisoners
Patients undergoing cancer surveillance
Single group
Electronic Health Record Review
Other interventionAncillary studies
Smartphone Application-based Intervention
BehavioralReceive access to MyCap application
Survey Administration
Other interventionAncillary studies
Retention rate (feasibility)
Defined as the number of participants who enroll in the study and complete at least one time log during the study period.
Adherence rate (feasibility)
Adherence is defined as the percentage of patients who completed over 80% of time logs. Given that this study is evaluating a daily time log over 8 weeks, adherence would require participants to fill out at least 44-time logs.
System usability survey (feasibility)
Click on the lead sponsor to view all of their trials.
